The core technology of detecting "intent" is viewed as a platform. Once the implant is in place for stroke recovery, it can be trained to detect cognitive lapses and provide real-time prompts, creating a system to assist with conditions like dementia or MCI.
Beyond the technology, Epia Neuro's strategy focuses on "surgical scalability." The implant procedure is designed to be under an hour, minimally invasive (not piercing the dura), and performable by many neurosurgeons, avoiding the bottleneck of requiring specialized centers for adoption.
To manage expectations with patients and regulators, Epia Neuro carefully frames its device as an "assisted living solution" that helps with daily tasks for life, while acknowledging that any brain retraining benefits are currently unknown and not the primary claim.
The company's AI doesn't try to precisely decode the brain's original signals for specific finger movements. Instead, it's trained to correlate broader brain activity patterns with the user's general intent to grip, making the system more robust and adaptable.